YOLFTbeta
BrightBid Group AB (publ)

BrightBid Group AB (publ)

PERP-B · ST · Healthcare / Medical Devices

1.95SEK+0.01 (+0.78%)

Price History

Full chart

Market Stats

Previous Close1.94
Open1.77
Day Range1.77 – 1.95
52-Week Range2.13 – 6.00
Volume12.25K
Market Cap19.85M
P/E (TTM)8.29
Forward P/E0.00
EPS0.28
Dividend Yield0.00%
Beta2.06
50-Day Avg3.01
200-Day Avg3.58

About

Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024. Perpetua Medical AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden. Perpetua Medical AB (publ) operates as a subsidiary of Nolsterby Invest AB.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Anders Hedlund
  • Employees12
  • HeadquartersKnivstagatan 8, Uppsala, Sweden, SE-753 23, Sweden
  • Websitehttps://perpetuamedical.se

Leadership

  • Mr. Anders HedlundCo-Founder & CEO · b. 1985
  • Mr. Hans DahlinFounder & Advisor to CEO
  • Ms. Camilla LonnChief Financial Officer · b. 1972
  • Mr. Thomas PousetteChief Legal Officer · b. 1964

Financials

Income Statement

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue212.00K682.00K1.02M242.20K13.97K798.33K1.03M2.18M1.90M8.82M10.11M9.94M6.94M14.56M
Growth (%)-+221.70%+48.97%-76.16%-94.23%+5616.22%+29.65%+110.82%-12.88%+363.76%+14.72%-1.76%-30.16%+109.83%
Cost of Revenue---1.02M165.13K--248.00K228.43K640.78K956.71K2.89M3.47M4.09M3.80M6.96M
Gross Profit212.00K682.00K1.02M77.07K13.97K1.05M806.10K1.54M944.37K5.93M6.65M5.85M3.14M7.60M
Gross Margin100.00%100.00%100.00%31.82%100.00%131.15%77.88%70.62%49.68%67.25%65.71%58.85%45.27%52.20%
Operating Expense839.00K1.41M2.00M7.46M11.15M10.70M13.11M17.02M15.46M19.61M25.76M24.34M5.60M5.56M
Operating Income-627.00K-732.00K-986.00K-7.38M-11.13M-9.65M-12.30M-15.47M-14.51M-13.68M-19.11M-18.49M-2.46M2.04M
Operating Margin-295.75%-107.33%-97.05%-3047.84%-79707.86%-1208.78%-1188.50%-709.21%-763.49%-155.22%-188.95%-186.11%-35.39%14.04%
EBITDA-602.00K-15.00K-961.00K-6.27M-9.84M-8.29M-10.89M-15.24M-13.94M-13.18M-18.65M-18.02M-1.80M4.40M
EBITDA Margin-283.96%-2.20%-94.59%-2588.31%-70449.66%-1039.05%-1052.37%-698.67%-733.35%-149.48%-184.37%-181.39%-25.98%30.19%
Net Income-718.00K-1.51M-1.06M-7.47M-11.24M-9.94M-12.38M-16.73M-14.59M-13.71M-19.16M-18.28M-2.47M2.45M
Net Income Margin-338.68%-221.70%-104.04%-3083.76%-80459.69%-1245.60%-1196.62%-766.68%-767.39%-155.54%-189.48%-183.95%-35.64%16.84%
R&D-----889.23K889.23K889.23K------
R&D as % of Total Revenue-----111.39%85.92%40.75%------
Interest Expense--71.36K87.01K104.99K286.50K86.44K70.18K147.62K149.17K129.19K75.00K78.83K703.00K
Interest Expense % of Total Revenue--7.02%35.92%751.78%35.89%8.35%3.22%7.77%1.69%1.28%0.75%1.14%4.83%

Balance Sheet

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.02M4.85M7.71M7.48M6.13M15.36M17.87M20.25M18.96M25.59M18.85M12.31M18.75M62.22M
Total Liabilities1.96M643.00K1.58M1.95M4.81M4.12M4.14M3.23M3.99M4.76M4.82M4.24M7.88M31.44M
Total Equity4.06M3.26M6.12M5.53M1.32M11.24M13.72M17.03M14.97M20.83M14.03M8.07M7.85M19.76M
Cash1.44M336.00K1.65M2.11M1.07M2.74M13.57M16.60M16.43M19.06M10.69M5.53M9.40M4.33M
Total Debt--833.33K633.33K2.43M2.23M1.76M1.39M1.06M749.34K388.89K56.00K4.00M178.00K
Net Debt--336.00K-817.64K-1.47M1.36M-510.46K-11.82M-15.21M-15.38M-18.31M-10.30M-5.48M-5.40M-4.16M

Cash Flow

Currency: SEK2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-230.00K-867.00K-1.11M-5.86M-9.16M-9.34M-11.03M-13.86M-10.21M-15.34M-19.19M-16.41M-7.03M-5.46M
Investing Cash Flow-240.00K-769.00K-1.33M-358.86K-700.45K-662.13K-357.67K-2.81M-4.39M-1.30M-1.01M-865.00K4.78M-8.25M
Financing Cash Flow1.63M534.00K3.76M6.68M8.82M19.67M14.22M19.67M13.19M19.26M11.83M12.12M6.12M8.64M
Capital Expenditure015.00K1.28M358.86K700.45K662.13K405.61K229.94K204.37K795.40K1.05M620.00K33.43K1.07M
Free Cash Flow-230.00K-882.00K-2.39M-6.22M-9.86M-10.00M-11.44M-14.09M-10.41M-16.13M-20.24M-17.03M-7.06M-6.53M
FCF to OCF100.00%101.73%215.69%106.12%107.65%107.09%103.68%101.66%102.00%105.19%105.48%103.78%100.48%119.59%

Earnings

Report DateDec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------
EPS Actual-25.76-23.92-18.79-15.88-24.04-16.60-15.52-17.75-11.48-12.25-10.74-6.37-8.14-10.09-9.53-6.12-11.23-6.50-4.70-6.85-8.60-3.50-7.30-4.91-3.78-5.39-5.90-3.83-6.88-4.12-6.90-1.74-1.460.61-0.46-0.25-0.30-0.29-0.181.65-0.57-0.24-0.25
Surprise-------------------------------------------
Timing-------------------------------------------

Key Statistics & Ratios

Market Cap19.85M
Enterprise Value5.85M
Trailing P/E8.29
Forward P/E0.00
Price / Sales1.01
Price / Book1.40
EPS0.28
Book Value1.88
Revenue (TTM)19.58M
Gross Profit (TTM)9.53M
EBITDA1.93M
Profit Margin1.73%
Operating Margin-51.91%
Return on Equity-15.56%
Return on Assets-3.98%
Shares Outstanding8.56M
Shares Float5.98M
Beta2.06
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
3.50Apr 16, 2021

Stock Splits

  • Sep 26, 20241:24
  • May 4, 20181:2